What topics does this cannabis study cover?

This study covers research on: THC, Mental Health.

THC may alter PTSD brain control circuits without felt changes

Q: What did this research study find?

Compared with placebo, **both oral THC doses reduced activation** in *prefrontal* and parietal regions involved in cognitive reappraisal of negative images.

Q: Where was this research published?

Published in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology on July 16, 2026.

Dose-related reductions in prefrontal recruitment during cognitive reappraisal following oral delta-9-tetrahydrocannabinol in posttraumatic stress disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology • July 16, 2026 • Highly Relevant

🤖

AI Summary

In a randomized, double-blind, placebo-controlled study, adults with posttraumatic stress disorder (PTSD) received placebo, 5 mg, or 10 mg of oral dronabinol, a synthetic form of THC, before completing an emotional regulation task during fMRI. Compared with placebo, both THC doses were linked to reduced activity in prefrontal and parietal brain regions involved in cognitive reappraisal—the process of changing how a distressing situation is interpreted. The reduction was broader and stronger after 10 mg.

Despite these changes in brain activity, participants’ reported negative feelings, stimulus ratings, and arousal did not reliably differ by dose. The findings therefore suggest a possible neural–subjective dissociation: acute oral THC may alter brain systems involved in emotional control without producing detectable changes in how people report feeling. For cannabis users and clinicians, the results do not show that THC improves PTSD-related emotion regulation; instead, they highlight that THC’s effects on underlying brain circuitry may differ from its immediately noticeable psychological effects. The study was relatively small, and subtle behavioral effects may not have been detectable.

💡 Key Findings

Compared with placebo, both oral THC doses reduced activation in prefrontal and parietal regions involved in cognitive reappraisal of negative images.

Good

78%

The reduction in prefrontal control circuitry was broader and stronger at 10 mg than at 5 mg, indicating a dose-related neural effect.

Good

78%

Despite changes in brain activation, self-reported negative affect, valence, and arousal did not reliably differ by dose.

Good

72%

The results are consistent with a possible neural–subjective dissociation, although smaller behavioral effects may have been missed in this sample.

Moderate

58%

📄 Original Abstract

Posttraumatic stress disorder (PTSD) is characterized by difficulties in emotion regulation and altered recruitment of prefrontal control systems during cognitive reappraisal. Cannabinoid signaling has been implicated in stress and affect regulation, yet dose-dependent effects of acute delta-9-tetrahydrocannabinol (THC) on the neural mechanisms supporting reappraisal in PTSD remain unclear. In a randomized, double-blind, placebo-controlled design, adults with PTSD received a single oral dose of placebo (N = 12), 5 mg dronabinol (synthetic THC; N = 12), or 10 mg dronabinol (N = 13) prior to fMRI during a validated cognitive reappraisal task. Relative to placebo, both THC doses were associated with reduced activation during reappraisal of negative images (Reappraise-Negative > Maintain-Negative) across prefrontal and parietal regions implicated in top-down control, with broader and stronger attenuation at 10 mg. In contrast, in-scanner negative affect ratings were robustly sensitive to task conditions but did not differ by dose. Post-scan valence and arousal ratings confirmed expected stimulus effects without reliable dose effects. Exploratory analyses revealed limited correspondence between regional activation and subjective affect. These findings indicate that acute oral THC is associated with dose-dependent reductions in recruitment of prefrontal control circuitry during cognitive reappraisal in PTSD without detectable changes in self-reported affect, consistent with a potential neural-subjective dissociation, although smaller behavioral effects may not have been detectable in the current sample.